1-Minute Consult

Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?

Richard Sekerak, MD, Johanna Ben-Ami Lerner, MD, Pooja Prasad, MD and Megha Prasad, MD
Cleveland Clinic Journal of Medicine October 2023, 90 (10) 607-609; DOI: https://doi.org/10.3949/ccjm.90a.23004

Article Information

vol. 90 no. 10 607-609
DOI 
https://doi.org/10.3949/ccjm.90a.23004
PubMed 
37783497
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online October 2, 2023.
Copyright & Usage 
Copyright © 2023 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Richard Sekerak, MD⇑
  1. Columbia University Medical Center, New York, NY
  1. Address:
    Richard Sekerak, MD, Columbia University Medical Center, 630 W 168th Street, New York, NY 10032; ris9105{at}nyp.org
  1. Johanna Ben-Ami Lerner, MD
  1. NYU Langone, New York, NY
  1. Pooja Prasad, MD
  1. Oregon Health Science University, Portland, OR
  1. Megha Prasad, MD
  1. Assistant Professor of Medicine, Columbia University Medical Center, New York, NY
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects